STERIS Stock (NYSE:STE)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$207.22

52W Range

$195.14 - $269.44

50D Avg

$215.95

200D Avg

$239.71

Market Cap

$20.26B

Avg Vol (3M)

$759.97K

Beta

0.92

Div Yield

$2.52 (1.21%)

STE Company Profile


STERIS plc operates as a global provider, delivering a wide array of products and services crucial for infection prevention and various procedural needs. The company's operations are strategically divided into four primary segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare division offers a comprehensive suite of solutions, encompassing specialized cleaning chemicals and sterility assurance products. It also provides automated systems for endoscope reprocessing and tracking, alongside critical capital equipment for sterile processing departments, such as washers, sterilizers, and accessories for gastrointestinal (GI) procedures. Additionally, this segment furnishes essential operating room equipment, including surgical tables, lighting, and connectivity solutions. Beyond products, the Healthcare division offers extensive support services, which include equipment management, installation, maintenance, upgrades, repairs, and troubleshooting for capital assets. It also delivers preventive maintenance programs, general repair services, and specialized instrument and endoscope repair. Furthermore, the division provides tailored consulting for process improvement and manages outsourced sterile processing services for instruments. The Applied Sterilization Technologies segment specializes in offering outsourced sterilization and testing services. These are provided to manufacturers of medical devices and pharmaceuticals through its expansive network of approximately 50 dedicated contract sterilization and laboratory facilities. In the Life Sciences sector, STERIS focuses on the design, production, and sale of consumable items. These include formulated cleaning chemistries, barrier and sterility assurance products, various sterilizers (both steam and vaporized hydrogen peroxide), and washer disinfectors. This segment also provides equipment installation, maintenance, upgrades, repairs, and troubleshooting, in addition to preventive maintenance programs. Finally, the Dental segment caters to dental practices by supplying a range of hand and powered dental instruments, infection control solutions, personal protective equipment (PPE), and products designed to maintain water quality within dental suites. STERIS's diverse portfolio of products and services reaches a broad clientele, including hospitals, other healthcare institutions, and pharmaceutical manufacturers. Established in 1985, STERIS plc maintains its corporate headquarters in Dublin, Ireland.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

18,000

IPO Date

Jun 01, 1992

Website

STE Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 26Mar 25Mar 24
Product$3.06B$2.87B$2.76B
Service$2.88B$2.59B$2.37B

Fiscal year ends in Mar 26 | Currency in USD

STE Financial Summary


Mar 26Mar 25Mar 24
Revenue$5.94B$5.46B$5.14B
Operating Income$1.10B$866.64M$836.12M
Net Income$785.10M$614.64M$378.24M
EBITDA$1.10B$1.36B$1.41B
Basic EPS$7.93$6.24$3.83
Diluted EPS$7.93$6.20$3.81

Fiscal year ends in Mar 26 | Currency in USD

Latest Earnings Call Transcripts


Q4 26May 12, 26 | 12:00 AM
Q3 26Feb 05, 26 | 9:00 AM
Q2 26Nov 06, 25 | 9:00 AM

Peer Comparison


TickerCompany
WATWaters Corporation
BIIBBiogen Inc.
SNNSmith & Nephew plc
PHGKoninklijke Philips N.V.
ZBHZimmer Biomet Holdings, Inc.
WSTWest Pharmaceutical Services, Inc.
DGXQuest Diagnostics Incorporated
PODDInsulet Corporation
LHLabcorp Holdings Inc.
DXCMDexCom, Inc.